South Korean steel giant Posco said Thursday that the company completed a new high-strength steel plant in China in a preemptive measure to respond to soaring demand from the burgeoning Chinese electric vehicle market. The new facility, located at Posco-CSPC (China Suzhou Processing Center), is a plant specialized in producing “Giga Steel,” the brand name for Posco’s advanced ultra-high tensile strength steel. The company said the advanced high-strength steel product can withst

Celltrion's adalimumab biosimilar CT-P17 has been approved the US Food and Drug Administration, the company announced Wednesday. CT-P17, also known as Yuflyma, is the world’s first high-concentration, low-volume and citrate-free biosimilar of Humira, an injectable treatment for rheumatoid arthritis and other autoimmune conditions. Celltrion said CT-P17 had been approved as a treatment for multiple chronic inflammatory diseases, including rheumatoid arthritis, inflammatory bowel diseas

Demand for cold medicines has increased recently, as the seasonal flu has continued longer than usual. With the spurt in cold and flu cases, sales of cold medicines have increased while some pharmacies face shortages, according to data from the government and local pharmaceutical companies on Tuesday. “Demand for over-the-counter cold medicines seems to be higher than usual, and some prescription medications for cold and flu are difficult to get,” a pharmacist operating a pharmacy in

The nation’s largest discount store chain E-mart, owned by retail giant Shinsegae Group, suffered dismal sales in the first quarter this year, outpaced by its smaller rival Coupang for the first time, with a gloomy outlook for the rest of the year, according to local brokerage firms Monday. In the first three months of the year, E-mart posted 13.7 billion won ($10.3 million) in operating profits, a 60.2 percent fall from a year ago. Net profit also plunged more than 90 percent to 2.7 billi

Celltrion Healthcare, Celltrion’s overseas sales and marketing unit, announced Monday that the company has launched its Remsima SC in Brazil, the largest pharmaceutical market in South America. Remsima SC is Celltrion’s under-the-skin injection of infliximab biosimilar. In Brazil, the infliximab biosimilar received sales approval from the Brazilian Health Regulatory Agency in November. Celltrion Healthcare will be in charge of direct sales of the infliximab biosimilar in Brazil thr

People in South Korea's top 1 percent net asset bracket had at least around 3 billion won ($2.26 million) in net assets in 2021, according to a local insurance firm’s report, Sunday. Net assets refer to the value of a person’s assets such as houses, cars, investments and cash, minus liabilities. According to Hanwha Life Insurance, individuals who had more than 2.9 billion won in net assets sat in the top 1 percent net asset bracket, while the threshold for the 0.1 percent bracke

Purchasing a package holiday can be a convenient option for travelers but may not be the ideal choice for people who dislike ticking off a list of famous tourist spots and attractions. Founded as a startup in 2020, DayTrip is an app that aims to provide well-curated and eye-catching travel content not provided by more conventional travel companies and platforms. “We started (DayTrip) during the COVID-19 pandemic, (which) was a very difficult time for us to make a travel platform,” Da

Prices of popular eating out options at restaurants continued to increase in April, adding more pressure to people’s consumption, a state-led agency’s data showed Wednesday. According to the Korea Consumer Agency data, the average price of a bowl of jajangmyeon, or noodles in black bean sauce, in Seoul increased by 12.5 percent on-year to 6,915 won ($5.20), up from 6,146 won a year ago. The average price of a bowl of samgyetang -- ginseng chicken soup that is popular during the summe

LG Chem CEO Shin Hak-cheol said Tuesday that the company will expand its sales of battery materials to 30 trillion won ($22.4 billion) by 2030, a sixfold increase from 4.7 trillion won in 2022. Shin added the company also aims to make its annual sales from three growth drivers -- battery materials, sustainability businesses and pharmaceuticals -- to reach 40 trillion won by 2030, which will make up 57 percent of the company’s total annual sales. LG Chem’s mid-term growth plan was unv

South Korean e-commerce firm Coupang is catching up with Shinsegae, one of the country's largest and oldest retail players, by closing the sales gap to less than 10 billion won ($7.5 million) from 1 trillion won a year ago, according to their earnings reports Friday. The 13-year-old e-commerce operator's increasing number of paid subscribers is the main driver behind its improved performance, posing threats to conventional retail brands like Shinsegae. According to Coupang's lates

South Korea’s CJ Logistics said Thursday that the company will invest around 60 billion won ($45.4 million) to establish a global distribution center in Saudi Arabia, the Middle East's rising logistics powerhouse. The distribution center will be located in Riyadh’s Special Integrated Logistics Zone, a special economic zone, through which the Saudi Arabian government aims to boost the country’s supply chains. The facility will be built on 18,000 square meters of land within

Celltrion said Tuesday that the company decided not to acquire BioPharma Solutions, a leading provider of sterile contract manufacturing solutions owned by US-based medical device maker Baxter International. “Celltrion reviewed the acquisition but decided not to make the investment,” an official from Celltrion said. Celltrion’s announcement came after Baxter International's statement was released on Monday, in which the company said it signed a definitive agreement to dive

SK Bioscience signed a contract manufacturing agreement with MSD to produce the latter’s next-generation Zaire ebolavirus vaccine candidate, the company said Monday. MSD is developing a next-generation Zaire Ebola vaccine candidate with Hilleman Laboratories to improve the production efficiency and thermal stability of the existing Zaire Ebola vaccine, Ervebo, which was approved in 2019. The development of MSD's new vaccine is in the early stage, and detailed manufacturing plans, howe

The number of female employees who are in their 30s has increased by around 110,000 from a year ago, while that of male workers in the same age group has declined by some 80,000, according to government data, Sunday. According to Statistics Korea and Microdata Integrated Service, the number of female workers who are aged 30-39 reached 2.17 million, up 108,000 from a year ago. The figure for male workers in the age group reached 3.12 million, down 84,000 on-year. In total, the number of employed

SK Bioscience’s share price soared over 16 percent on Thursday after the company signed a manufacturing deal with international pharmaceutical firm MSD. According to the Health Ministry and SK Bioscience on Friday, SK Bioscience and MSD inked the contract manufacturing deal to produce a vaccine. Following the signing, SK Bioscience’s stock price increased 16.39 percent to 83,100 won ($64.04) on Thursday, largely on the hopes that the company's sluggish performance will improve i

The United States is expected to become South Korea’s top trading partner for the first time in 20 years, replacing China, Korea’s current top export destination, government data showed Friday. According to the Trade Ministry's latest data, South Korea’s exports to China in April decreased by 26.5 percent on-year to $9.52 billion. The country's exports to the US, on the other hand, reached $9.18 billion. The gap between South Korea’s exports to China and the US

Six major South Korean business lobby groups issued a joint statement Thursday, calling on the National Assembly to amend related laws to keep telehealth platforms running. The groups, including the Korea Chamber of Commerce and Industry and the Federation of Korean Industries, asked lawmakers to legislate the medical law amendment bill to protect the telemedicine industry. Telemedicine services boomed in Korea during the height of the COVID-19 pandemic, but they soon may no longer be available

Consumer prices for hamburgers rose at the fastest clip in nearly 20 years, according to Statistics Korea data released on Thursday, after major franchise companies raised their prices on the back of increasing expenses on raw materials. Hamburger prices rose 17.1 percent on-year last month, the highest jump since July 2004 when they increased by 19 percent. In Korea, the inflation rate of hamburgers has been rising fast this year. Consumer prices for hamburgers in February rose by 7.1 percent a

Merck, a leading science and technology company based in Germany, said Wednesday it plans to build a bioprocessing unit in Daejeon, South Korea. Under a three-way memorandum of understanding signed by the firm with Korea's Ministry of Trade, Industry and Energy and the government of Daejeon, they will discuss detailed plans for building the international pharmaceutical company’s new bioprocessing unit that can produce raw materials for drugs. The Trade Ministry and the Daejeon city go

Collective efforts from a global network of vaccine developers and manufacturers will be needed to better respond to future outbreaks and pandemics, said a co-developer of a COVID-19 vaccine that has saved millions of lives. Sarah Gilbert, professor of vaccinology at the University of Oxford and co-developer of the Oxford-AstraZeneca COVID-19 vaccine, warned that more pandemics will occur in the future. “There needs to be a global collaboration and recognition that we need vaccines for pub